close

JLABS | Paths to the patient: Business models for drug discovery and development Utrecht, The Netherlands

3 June 2025 | 13:00 – 18:00 CEST | Utrecht & virtual

Turning a drug discovery into patient impact means choosing the right development path and knowing when to pivot. But how do you choose the best route for your drug?

Join Johnson & Johnson’s upcoming program as they bring together experts who have successfully traveled these paths and are ready to share insights into various development routes. Topics include academic-industry partnerships, IP strategies, spin-off creation, funding, and more.

Don’t miss your chance to gain clarity on the pros and cons of different paths for your scientific breakthrough. 

Start-ups, early innovators and entrepreneurs are welcome to register here.